知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Yu, Jing 南京医科大学被知名学者引用:105人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Lilach O,Lerman 美国 Mayo Clinic - Rochester 1986美国科学院院士 Obesity Blunts the Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles

2. Susan L,Furth 美国 University of Pennsylvania 2023美国医学院院士 Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Res..

3. Paul M,Ridker 美国 Harvard Medical School 2020美国医学院院士 Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

4. Shizuo,Akira 日本 WPI Immunology Frontier Research Center, Osaka University 2009美国科学院院士 Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in..

5. Iichiro,Shimomura 日本 Osaka University Pharmacological HIF-1 activation upregulates extracellular vesicle production synergistically with a..

6. 游潮 中国 四川大学 Decoding the biology and clinical implication of neutrophils in intracranial aneurysm

7. 宋伟宏 中国 温州医科大学 The role of inflammasomes in human diseases and their potential as therapeutic targets

8. David J,Lefer 美国 Louisiana State University Cardiovascular dysfunction induced by combined exposure to nicotine inhalation and high-fat diet

9. Lazartigues, Eric 美国 Louisiana State University Cardiovascular dysfunction induced by combined exposure to nicotine inhalation and high-fat diet

10. Mitch, William E. 美国 Baylor College of Medicine Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation

11. Dobromir,Dobrev 德国 University of Duisburg-Essen Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation

12. Xander H.T,Wehrens 美国 Baylor College of Medicine Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation

13. Kai-Uwe,Eckardt 德国 Charite - Medical University of Berlin Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

14. Volker H,Haase 美国 VANDERBILT University Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

15. Kirsten L,Johansen 美国 University of Minnesota Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

16. Masaomi,Nangaku 日本 University of Tokyo Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

17. Navdeep,Tangri 加拿大 University of Manitoba Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

18. Sushrut S,Waikar 美国 Boston University Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

19. Michel,Jadoul 比利时 Universite Catholique de Louvain Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

20. Wolfgang C,Winkelmayer 美国 Baylor College of Medicine Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Globa..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3